Brian M. Culley
President and CEO at Lineage Cell Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Lineage Cell Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Lineage Cell Therapeutics Inc. June 9, 202698.2%
-
Lineage Cell Therapeutics Inc. June 26, 202598.1%
-
Lineage Cell Therapeutics Inc. June 11, 202498.1%
-
Lineage Cell Therapeutics Inc. September 6, 202398.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 | Lineage Cell Therapeutics Inc. | Open-market purchase | +15,000 | $1.63 | $24,450 |
| Feb 11, 2026 | Lineage Cell Therapeutics Inc. | Option exercise | +31,250 | — | — |
| Feb 11, 2026 | Lineage Cell Therapeutics Inc. | Shares withheld for tax | −12,869 | $1.80 | $23,164 |
| Dec 19, 2025 | Lineage Cell Therapeutics Inc. | Grant or award | +8,925 | — | — |
| Dec 19, 2025 | Lineage Cell Therapeutics Inc. | Shares withheld for tax | −334 | $1.68 | $561 |
| Feb 11, 2025 | Lineage Cell Therapeutics Inc. | Option exercise | +31,249 | — | — |
| Feb 11, 2025 | Lineage Cell Therapeutics Inc. | Shares withheld for tax | −12,547 | $0.65 | $8,156 |
| Nov 21, 2024 | Lineage Cell Therapeutics Inc. | Open-market purchase | +40,000 | $0.60 | $24,000 |
| May 24, 2024 | Lineage Cell Therapeutics Inc. | Open-market purchase | +10,000 | $1.05 | $10,500 |
| Feb 11, 2024 | Lineage Cell Therapeutics Inc. | Option exercise | +31,249 | — | — |
| Feb 11, 2024 | Lineage Cell Therapeutics Inc. | Shares withheld for tax | −12,806 | $1.08 | $13,830 |
| Feb 11, 2023 | Lineage Cell Therapeutics Inc. | Option exercise | +31,249 | — | — |
| Feb 11, 2023 | Lineage Cell Therapeutics Inc. | Shares withheld for tax | −12,744 | $1.35 | $17,204 |
Questions about Brian M. Culley
What boards is Brian M. Culley on?
Brian M. Culley sits on the board of Lineage Cell Therapeutics Inc.
What company is Brian M. Culley the CEO of?
Brian M. Culley is President and CEO of Lineage Cell Therapeutics Inc.
How long has Brian M. Culley served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.